Could a simple scan prevent deadly liver failure after surgery?
NCT ID NCT07358975
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a special imaging scan (Tc-GSA SPECT/CT) to see if it can predict liver failure after surgery for liver tumors. About 192 adults in Denmark will receive the scan before their operation. The goal is to compare this new method with standard tests and find the best way to identify high-risk patients, potentially improving surgical safety.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Technetium-99m galactosyl human serum albumin (Tc-GSA) injection
- What this could lead to
- If successful, this scan could help doctors better predict which patients are at risk of liver failure after surgery, leading to safer procedures and fewer complications.
- What could go wrong
- This is an early-phase study in a small group of patients in Denmark. The scan may not prove more accurate than existing tests, and results may not apply to other populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Rigshospitalet
Copenhagen, 2100, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.